Browsing by Author "Ozsan, Hayri (57222706769)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Erratum: A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: Analysis of parameters that improve outcome (Haematologica (2020) 10:51 (201-208) DOI: 10.3324/haematol.2019.219295)(2021) ;Beksac, Meral (56924887200) ;Seval, Guldane Cengiz (37091700000) ;Kanellias, Nicholas (35205659400) ;Coriu, Daniel (14053678600) ;Rosiñol, Laura (6602445850) ;Ozet, Gulsum (6602385011) ;Goranova-Marinova, Vesselina (25223127900) ;Unal, Ali (59081834500) ;Bila, Jelena (57208312102) ;Ozsan, Hayri (57222706769) ;Ivanaj, Arben (6504086390) ;Balić, Lejla Ibricevic (57212802542) ;Kastritis, Efstathios (8504977900) ;Bladé, Joan (55906349600)Dimopoulos, Meletios Athanasios (55978800700)We have noticed an error in the progression-free survival of patients with extramedullary plasmacytoma in our article published in Haematologica in January 2020 (doi: HAEMATOL/2019/219295). The following sentence in the abstract: “Extramedullary plasmacytoma at relapse had the worst prognosis with a PFS of 13.6 months and overall survival of 11.4 months.” Should be replaced by: “Extramedullary plasmacytoma at relapse had the worst prognosis with a PFS of 9.1 months and overall survival of 11.4 months.” Likewise, on page 205, the following sentence: “However, if diagnosed at relapse, PFS and OS were 13.6 months and 11.4 months for EMP compared to 20.9 months (P=0.249) and 39.8 months (P=0.093) for PO, respectively (Table 2 and Figure 1).” Should be replaced by: “However, if diagnosed at relapse, PFS and OS were 9.1 months and 11.4 months for EMP compared to 20.9 months (P=0.249) and 39.8 months (P=0.093) for PO, respectively (Table 2 and Figure 1).” The error was also present in Table 2. The corrected Table 2 is shown below. © 2021 Ferrata Storti Foundation
